Systemic therapies damage cancer cells that have broken off from the key tumor (the spot exactly where the cancer starts off) and spread. This includes advanced cancers that have spread to distant body pieces (metastatic cancer).Performing better, it seems, requires building fantastic linker molecules that tie the antibody on the drug. These small